Stocks Hitting 52-Week Highs

Regulus Therapeutics RGLS shares reached a new 52-week high of $25.251. Regulus Therapeutics shares have jumped 265.56% over the past 52 weeks, while the S&P 500 index has gained 14.68% in the same period. BioMarin Pharmaceutical BMRN shares touched a new 52-week high of $87.09. Goldman Sachs upgraded BioMarin Pharmaceutical from Neutral to Buy and raised the price target from $78.00 to $104.00. Jarden JAH shares rose 0.47% to touch a new 52-week high of $66.54. Jarden's PEG ratio is 1.39. Norfolk Southern NSC shares gained 2.21% to reach a new 52-week high of $115.36. Norfolk Southern's trailing-twelve-month revenue is $11.64 billion.